Different regulatory mechanisms of the capsule in hypervirulent Klebsiella pneumonia: “direct” wcaJ variation vs. “indirect” rmpA regulation

Introduction

Hypervirulent Klebsiella pneumoniae (hvKp) has recently elicited concern because of its ability to cause serious invasive disease, such as liver abscesses, bacteremia, and pleural empyema (Russo and Marr, 2019; Chen et al., 2021). Unlike classic K. pneumoniae strains, hypervirulent strains typically possess a thick, hypermucoid capsule (Paczosa and Mecsas, 2016). The capsule is a key virulence factor that renders hvKp resistant to the complement system and to phagocytosis (Xu et al., 2021). However, the mechanisms underlying capsule production and pathogenicity remain unclear.

To date, studies have demonstrated that capsule synthesis is affected by many different regulatory elements, such as RmpA/RmpA2, KvrA/KvrB, CRP, and RcsAB (Walker and Miller, 2020). Among these, rmpA/A2 is a major regulator of the mucoid phenotype of K. pneumoniae. Studies have shown that both the salmochelin (iroBCDN)/aerobactin (iucABCDiutA) systems and rmpA/A2 are found on the large plasmid of almost all reported hvKp strains (Struve et al., 2015). However, it is unknown how rmpA/A2 regulates the synthesis of capsules in hvKp strains.

The genes needed for capsule synthesis are located on a chromosomal operon, cps. Approximately 110 types of capsule have been defined in Klebsiella spp.; each has a distinct capsular polysaccharide (CPS; also called K antigen) chemical structure (Follador et al., 2016). Nevertheless, the most common capsule locus associated with hvKp is K1, followed by K2 (Fung et al., 2002; Lee et al., 2016). Moreover, based on extensive results from mouse experiments, K1 and K2 strains are generally more virulent than strains of other serotypes (Mizuta et al., 1983; Yu et al., 2008), suggesting that distinct capsules can lead to differences in bacterial virulence.

The cps cluster locus comprises three main components: at the 5’ end, six relatively conserved genes (galF, orf2, wzi, wza, wzb, and wzc) are responsible for the transportation and processing of CPSs; the highly variable middle region regulates the assembly and polymerization of the CPSs; and the 3’ end region mainly determines the synthesis of monosaccharides, with all these sequences being highly conserved (Shu et al., 2009). Furthermore, the capsules of K. pneumoniae are synthesized via a wzy-dependent pathway. Generally, the synthesis of the capsular repeat is initiated by the initial glycosyltransferase (GT)–WbaP or WcaJ (Whitfield, 2006) and further catalyzed by specific (non-initial) GTs, allowing the addition of sugars (Whitfield, 2006). The lipid-linked repeat units are flipped across the plasma membrane by Wzx and then polymerized by Wzy (Whitfield and Roberts, 1999). Subsequently, the channel Wza, together with regulators Wzb and Wzc, which control the process of polymerization and transportation, exports the polymer to the surface of the bacterium (Shu et al., 2009), where it is anchored to the cell surface by Wzi (an outer-membrane lectin) (Whitfield and Paiment, 2003; Bushell et al., 2013).

In conclusion, capsule synthesis is not only affected by regulatory factors, but is also associated with diversity among its constituent genes. In the present study, to develop a better understanding of the process of capsule synthesis in hvKp strains, we aimed to analyze the effects of the initial glycosyltransferase gene in capsule synthesis (wcaJ* and of the capsular regulatory gene (rmpA) on capsule production.

Methods

Strains and definitions

All 188 sequenced strains of hypervirulent K. pneumoniae were available in the Genbank database (as of May 2022), and the characteristics of these genomes are listed in Table S1. Additionally, 530 K. pneumoniae clinical isolates were previously collected from nine hospitals in seven provinces between January 2017 and February 2018. We selected strains of the three main hypervirulent serotypes (K1, K2, and K64) from these K. pneumoniae isolates, for a total of 48 strains; the details of these strains are also provided in Table S1. MLST analysis was conducted using the Pasteur Institute MLST website for K. pneumoniae (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html). Additionally, K serotypes were determined using Kaptive 2.0 (https://github.com/katholt/kaptive). Virulence genes (iro and iuc; rmpA and rmpA2) were identified using the blastn tool (https://blast.ncbi.nlm.nih.gov/). Isolates were classified as the hvKp genotype if they contained iuc and/or iro, and rmpA and/or rmpA2.

Gene sequencing and phylogenetic analysis

PCR and sequencing were carried out to screen for the wcaJ/wbaP gene in isolates obtained from the Genbank dataset and from clinical sources. The primers employed are shown in Table S2. The wcaJ/wbaP sequences were aligned using the Clustal W software package, and maximum-likelihood phylogenetic trees were constructed using the MEGA v7.0.26 software package with 1000 bootstrap values.

Construction of plasmids and gene knockout strains

Plasmids pACYC-wcaJ^K1, pACYC-wcaJ^K2, and pACYC-wcaJ^K64 were constructed using the NEBuilder HiFi DNA Assembly Cloning Kit (NEB), following the manufacturer’s recommended protocol. Additionally, the pACYC184 plasmid was electrotransferred into NTUH-K2044 as a negative control.

The gene knockout strains K2044^ΔwcaJ and K2044^ΔrmpA were constructed using the λ-Red homologous recombination system, as previously reported (Datsenko and Wanner, 2000). The primer sequences employed are presented in Table S2. When necessary, appropriate antibiotics were added at the following final concentrations: chloramphenicol (chlo): 60 μg/mL for pACYC184; kanamycin (kana): 100 μg/mL for K2044^ΔwcaJ and K2044^ΔrmpA.

Growth conditions

The effect of wcaJ on the growth of K. pneumoniae was measured. In brief, overnight cultures of all K. pneumoniae strains were diluted at 1:100 in broth supplemented with different appropriate antibiotics. The cultures were incubated at 37°C and A₆₀₀ was measured every 30 min.

Transmission electron microscopy

K. pneumoniae bacteria in the mid-log growth phase were collected and fixed with 2.5% glutaraldehyde overnight at 4°C, then washed twice in 0.1 M phosphate buffer. Next, bacteria were post-fixed with 1% osmium tetroxide for 1 h, washed twice in 0.1 M phosphate buffer water, and washed twice in water. The samples underwent subsequent dehydration in increasing grades of alcohol (30%, 50%, 70%, 80%, 95%: 15 minutes; 100%: 2 × 10 min). Next, infiltration and embedding were performed using Spurr’s resin and samples were polymerized at 60°C for 48 h. Samples were examined using a Tecnai G2 Spirit Twin transmission electron microscope and corresponding images were recorded.

Mucoviscosity assay and capsule quantification

The mucoviscosity of the Klebsiella strains was measured as previously described (Bachman et al., 2015). An overnight culture grown in LB was diluted at 1:100 in media and grown at 37°C. At 6 h, the culture was centrifuged at 1000 × g for 5 min, followed by immediate measurement of the OD₆₀₀ of the supernatant.

Uronic acid was extracted and quantified as described previously (Mike et al., 2021); the test strains were cultured for 6 h. Subsequently, 500 µL culture was mixed with 100 µL of 1% Zwittergent 3–12 detergent and heated for 20 min at 50°C, then centrifuged for 5 min at 13,000 × g. Next, 300 µl of supernatant was mixed with 1.2 mL absolute ethanol and centrifuged for 5 min at 13,000 × g. The pellet was dried and resuspended in 200 µl of sterile water, to which 1.2 mL of tetraborate solution (12.5 mM sodium tetraborate in sulfuric acid) was added. This was incubated for 5 min at 100°C, followed by immediate cooling on ice for at least 10 min, which was then followed by addition of 20µl of hydroxyphenyl reagent. After 5 min incubation at room temperature, OD was determined at 520 nm.

Biofilm formation

Biofilm assay was performed, following previously published methods, in 96-well plates. Briefly, 200 μL of mid-log phase bacteria cells (1.5x10⁷CFU/ml) was added to a 96-well plate and incubated at 37°C for 24 h. All cultures were removed and the wells were washed twice with phosphate-buffered saline (PBS), then stained with 200 μL of 0.1% crystal violet for 20 min and rinsed twice with PBS. Stained biofilms were solubilized with 95% ethanol and quantified by measuring the OD₅₉₅ value.

Phagocytosis and invasion assays

RAW 264.7 murine macrophages were grown in DMEM medium supplemented with 10% FBS. Macrophages (1x10⁵/well) were seeded into 24-well plates and infected at a MOI of 50 (bacteria/cell). Subsequently, plates were centrifuged at 200 × g for 5 min and incubated at 37°C with 5% CO₂. After 1.5 h, cells were washed three times with PBS. Next, cells were further incubated for 1.5 h with meropenem to kill extracellular bacteria. Cells were then rinsed again three times with PBS and lysed with 0.2% Triton X-100 for 20 min. Serial dilutions of the lysate were plated for LB agar plates to determine the number of CFUs per unit volume. Three biological replicates per strain were used per experiment.

Mid-log-phase K. pneumoniae in DMEM medium containing 10% FBS were added to the wells (at MOI 50), incubated for 2 h, and washed three times with PBS. Cells were then incubated for 2 h with fresh medium containing meropenem. Finally, the number of intracellular bacteria was determined by the number of CFUs on the LB agar.

Serum resistance assay

For serum survival assay, the mid-log phase bacteria cells (1.5x10⁶ CFU/ml) were mixed with normal human serum at a 1:3 ratio and incubated at 37°C for 2 h. Bacteria were grown overnight in LB for enumeration of viable bacteria.

Infection model of Galleria mellonella larvae

G. mellonella killing assays were carried out on the six isolates. Ten larvae weighing approximately 300 mg were randomly selected for each strain. For each of these, 10 μl of bacterial suspension (1×10⁶ CFU/ml) in PBS or 10µl of PBS (control group) was injected into the last left proleg. The insects were incubated at 37°C in the dark and observed for 96 h. Larvae were considered dead when they repeatedly failed to respond to physical stimuli.

Quantitative RT-PCR

Total RNA was extracted from the bacteria in the logarithmic growth phase. Following this, the RNA was converted to cDNA using the PrimeScript™ RT Reagent Kit. Real-time PCR was performed using a LightCycler^® System. Relative gene expression levels were measured in terms of Ct values and analyzed using the 2^-ΔΔCt method. The primer sequences are presented in Table S3. RpoB was used as an internal control. Three biological replicates per strain were used.

Statistical analysis

All experiments were performed with biological replicates, and graphical and numerical data analysis was carried out using Graphpad Prism 9.0. Analyses included two-tailed Student’s t-tests, one-way analysis of variance (ANOVA), two-way ANOVA, and log-rank tests. Statistical significance was defined as p < 0.05.

Results

The distribution of wcaJ/wbaP in hvKp

Multilocus sequence typing (MLST) of 226 hvKp strains showed that ST11 was the most prevalent sequence type (ST), followed by ST23, ST48, and ST86 (Figure 1A). Additionally, the most prevalent capsule types were the K64, K1, and K2 serotypes (Figure 1B). These results are consistent with previous findings. Previously, hvKP strains have usually been found to be associated with sequence types ST23, ST65, and ST86 and with serotype K1/K2. However, in recent years, virulence plasmids have been acquired in CRKP strains to an increasing extent (ST11), creating hypervirulent and carbapenem-resistant K. pneumoniae (CR-hvKP) and resulting in widespread epidemics (Lan et al., 2021; Tian et al., 2022).

FIGURE 1

Figure 1 The distribution and sequence diversity of wcaJ/wbaP among hvKp strains. (A) MLST of the 226 completely sequenced hvKp strains available from GenBank. (B) The serotypes of the 226 hvKp strains available from GenBank. (C) A Klebsiella pneumoniae phylogenetic tree of wcaJ sequences in various K. pneumoniae serotypes. The tree was constructed using the maximum likelihood method with 1,000 bootstrap replicates in the MEGA7 software package. Different colors represent different serotypes. The strains marked with red star refer to nucleotide mutations in its wcaJ sequence.

We also analyzed the expression of wcaJ/wbap in different serotypes. Considering the transfer of Gal-1-P from UDP-galactose or UDP-glucose to und-P (Whitfield, 2006), we analyzed wcaJ and wbap sequences by constructing evolutionary trees separately. Firstly, as shown in Figure 1C, wcaJ was present in the K1, K2, K5, K16, K23, K24, K25, K30, K39, and K64 serotypes, whereas wbaP was present in the K19, K20, K21, K43, K47, K51, K57, K62, and K112 strains (Figure S1). The results showed that wcaJ and wbaP sequences of the same serotype were clustered in the same branch, indicating that wcaJ or wbaP sequences in the same serotype are relatively conserved. However, different nucleotide mutations also appeared in the wcaJ sequence of the same serotype, such as the K1 serotype (Figure S2).

The diversity of wcaJ/wbaP sequences in clinical isolates

To date, two main categories of hvKp serotype appear to have been identified: 1) K1 and K2; and 2) K64. Therefore, we next focused on studying the wcaJ sequences in the three common hvKp serotypes: K1, K2, and K64. To this end, a total of 48 hvKp isolates were collected from six hospitals, including K1 (n = 20), K2 (n = 13), and K64 (n=15). The results, as presented in Figure 2, showed that the wcaJ sequences were identical within strains belonging to the same serotype (including K1, K2, and K64 clinical strains). Furthermore, 75% of the K1 serotype was composed of ST23, while the K2 serotype comprised a greater variety of STs, such as ST65, ST86, and ST25. Finally, the K64 serotypes were mostly composed of ST11. Interestingly, a majority of the K1/K2 strains were hypermucoid, whereas most of the K64 strains were not. It is unknown whether different wcaJ sequences play an important role in hypercapsule formation.

FIGURE 2

Figure 2 The distribution of wcaJ among distinct Klebsiella pneumoniae serotypes (K1, K2, and K64) in 48 clinical hvKp isolates. Each color branch represents a different serotype. The wcaJ sequences within the same serotype are identical. The MLSTs are displayed for different strains; presence of hypermucoid (> 5 mm) or normal capsules was determined using string tests.

Capsule formation in different recombinant K. pneumoniae strains

The effect of wcaJ on capsule formation was analyzed by constructing various mutants: K2044^K1wcaJ, K2044^K2wcaJ, and K2044^K64wcaJ. We found that the K2044^K1wcaJ and K2044^K2wcaJ recombinants exhibited significantly slower rates of growth compared to other mutants (Figure 3A). However, the presence of pACYC184 plasmid did not affect the growth of the strain. The growth defects in K2044^K1wcaJ and K2044^K2wcaJ require further exploration. Next, electron microscopy results showed that K2044, K2044^K1wcaJ, and K2044^K2wcaJ (but not K2044^ΔwcaJ or K2044^K64wcaJ) produced a loose and thick mucus substance (Figure 3B), suggesting that the K2044^K64wcaJ mutants had impaired capsule formation abilities, similar to those of the K2044^ΔwcaJ mutants.

FIGURE 3

Figure 3 Capsule formation in various Klebsiella pneumoniae mutants. (A) The 12 h growth curves of different strains. (B) Transmission electron microscopy images of the capsule. Assessment of (C) the mucoviscosity of the culture supernatants, (D) the production of uronic acid, and (E) the formation of biofilm. K2044^ΔwcaJ was used as a negative control. An unpaired two-sided Student’s t-test was used for comparisons between K2044^ΔwcaJ and its mutants. Each data point represents an average of three independent replicates (n = 3). The values of culture supernatants, uronic acid, and biofilm formation were normalized to OD600. Data are presented in the form mean ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05, ns: not significant. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, ns, not significant.

Viscosity and uronic acid were subsequently measured. The results indicated that knockout of wcaJ significantly reduced capsular viscosity, and the complement of p-K1wcaJ or p-K2wcaJ caused hypercapsulation; these were even more hypermucoid than the K2044 parent strains (Figure 3C). In addition, capsule formation was quantified by measuring uronic acid. As shown in Figure 3D, decreased uronic acid was observed in K2044^ΔwcaJ, but K2044^K1wcaJ and K2044^K2wcaJ produced uronic acid to an extent similar to K2044. The biofilm, an important bacterial protective mechanism, is another substance existing on the surface of cells. There was an inverse correlation between capsule production and biofilm formation (Figure 3E), as the K2044^ΔwcaJ and K2044^K64wcaJ capsule-null mutants were better able to form biofilms than K2044, K2044^K1wcaJ, or K2044^K2wcaJ. Furthermore, there was no significant difference between K2044^ΔwcaJ and K2044^K64wcaJ in terms of capsular viscosity, uronic acid, or biofilm production.

Differences in CPS synthesis clusters and wcaJ sequences

To summarize, the plasmids carrying K64 wcaJ exhibited impaired capsule formation, whereas the complement of K2 wcaJ did not. The associated molecular mechanism was unclear. A comparison was made of the composition of cps loci among K1, K2, and K64 serotypes. The results revealed the presence of conserved genes within the three serotypes, including galF, wzi, wza, wzb, wzc, wcaJ, gnd, manC, manB, and ugd (Figure 4A). Additionally, wcaJ protein alignment showed that F244-Y467 were identical in K1 and K2, but not in the K64 serotype (Figure 4B).

FIGURE 4

Figure 4 Comparison of wcaJ sequences among K1, K2, and K64 serotypes. (A) The genetic differences between the cps clusters of the K1, K2, and K64 serotypes. (B) The WcaJ protein sequences in the K1, K2, and K64 serotypes. Alignment was performed using the MUSCLE sequence alignment tool.

Cell invasion and phagocytosis of different recombinants

Previous studies have demonstrated that the hypercapsule of hvKp is essential for resistance to phagocytosis. Compared with K2044^ΔwcaJ, the bacterial invasion of RAW264.7 and Caco2 cell lines was equally significantly suppressed in the K2044, K2044^K1wcaJ, and K2044^K2wcaJ groups. However, the number of bacterial invasions did not differ between the K2044^ΔwcaJ and K2044^K64wcaJ groups (Figure 5). The above results indicate that the presence of the capsule reduced the invasion and phagocytosis of hvKp strains.

FIGURE 5

Figure 5 The cell internalization phenotypes of different Klebsiella pneumoniae mutants. The invasion assay was performed in (A) macrophage RAW 264.7 cells and (B) intestinal epithelial Caco2 cells. The K2044^ΔwcaJ strain was taken as a control group. Data were analyzed via one-way ANOVA. Each data point represents three replicates. **P < 0.01, *P < 0.05, ns: not significant.

The effects of wcaJ on K. pneumoniae virulence

Since the capsule acts as an important virulence factor, we wondered whether wcaJ sequence variations could affect the virulence of hvKp isolates. As shown in Figure 6A, K2044, K2044^K1wcaJ. and K2044^K2wcaJ exhibited significantly higher levels of serum resistance than K2044^ΔwcaJ. As shown in Figure 6B, when the larvae were infected with the same bacterial inoculum, K2044^ΔwcaJ strains exhibited significantly decreased virulence levels compared to K2044, K2044^K1wcaJ, and K2044^K2wcaJ. K2044^K1wcaJ and K2044^K2wcaJ exhibited similar virulence effects to K2044, but K2044^K64wcaJ did not. The above results instead confirm that the synthesis of hypermucoviscous capsules significantly enhanced the virulence of a given K. pneumoniae strain.

FIGURE 6

Figure 6 The virulence phenotype of different Klebsiella pneumoniae mutants. (A) Serum resistance of K2044, K2044^K1wcaJ, K2044^K2wcaJ, and K2044^K64wcaJ, with K2044^ΔwcaJ as a reference. (B) The survival curves of infected Galleria mellonella larvae; a log-rank (Mantel–Cox) test was used to analyze the survival curves. (C-F) Production of the inflammatory cytokines (C) IL-1β, (D) IL-6, (E) IL-8, and (F) IFN-γ was measured by ELISA at 2, 8, 16, and 24 h. The K2044^ΔwcaJ mutant was analyzed as negative control, and two-way ANOVA tests were performed. Data are presented in the form mean ± SEM. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, ns, not significant.

The inflammatory response induced by wcaJ recombinants

To examine whether wcaJ mutants induced different inflammatory responses in vitro, RAW 264.7 cells were treated with different recombinants and cytokine production was measured by ELISA. The results showed that release of IL-1β reached a peak at 8 h (Figure 6C), IL-6 at 16 h (Figure 6D), IL-8 at 16 h (Figure 6E), and IFN-γ at 8 h (Figure 6F). Compared to K2044^ΔwcaJ, the K2044, K2044^K1wcaJ, and K2044^K2wcaJ strains significantly promoted the production of IL-6 and IL-8, but K2044^K64wcaJ did not. This phenomenon suggests that the presence of the capsule promoted the inflammatory response. Additionally, it is worth noting that no significant production of IL-1β or IFN-γ was observed (Figure 6F).

The regulatory effect of rmpA on the capsule

Studies have demonstrated there is a strong correlation between p-rmpA/rmpA2 and hypermucoviscosity/hypervirulence. Therefore, p-rmpA/rmpA2 is among a set of genes proposed as biomarkers for detection of hvKp strains (Russo et al., 2018). A poly-G frameshift leads to the early termination of p-rmpA2 transcription. The resulting truncated product is 99 amino acids long and lacks the C-terminal DNA-binding region. We therefore next focused on the regulatory effect of p-rmpA on capsule production and virulence.

Phylogenetic tree results indicated that rmpA sequence was conserved regardless of serotype (Figure 7). The CPS biosynthesis capacity of the K2044^ΔrmpA mutant was then determined. Compared to the K2044 strains, mucoviscosity and uronic acid were markedly decreased in the K2044^ΔrmpA mutants (Figures 8A, B). The cps locus contains three characterized promoters, which are located upstream of galF, wzi, and manC (Figure 8C). We found that the expression of galF, wzi, and manC was decreased in the K2044^ΔrmpA strains (Figure 8D). Thus, the capsule alterations described above may have been caused by the reduced expression of genes associated with CPS biosynthesis. In consideration of the changes affecting the capsule, the virulence of K2044^ΔrmpA mutants was evaluated via G. mellonella testing. The results demonstrated that the p-rmpA-mediated reduction in capsule production significantly impaired the virulence of K. pneumoniae in G. mellonella (Figure 8E).

FIGURE 7

Figure 7 Sequence diversity of rmpA among hvKp strains, illustrated by the phylogenetic tree of rmpA sequences in various serotypes of hvKp strains. The tree was constructed using the maximum likelihood method with 1,000 bootstrap replicates in the MEGA7 software package.

FIGURE 8

Figure 8 The effect of rmpA on the capsule and virulence of Klebsiella pneumoniae. (A) Capsule mucoviscosity. (B) Uronic acid production. (C) A diagram showing the location of cps clusters with the sequences of K2044 strains and the location of the relevant promoters. (D) qRT-PCR results for expression of galF, manC, and wzi in the K2044 and ΔrmpA strains (2^-ΔΔCt). (E) The Galleria mellonella infection model. A log-rank (Mantel–Cox) test was used to analyze the survival curves. Data were analyzed via one-way ANOVA. **P < 0.01, *P < 0.05.

Discussion

Hypervirulent K. pneumoniae strains are mainly divided into two categories: 1) common hvKp, which includes the K1 and K2 serotypes; and 2) newly-emerged carbapenem-resistant (CR)-hvKp, mainly in the form of K64 serotypes (Shon et al., 2013; Tian et al., 2022). This view is consistent with our results. The most prevalent capsule types were K64, followed by the K1 and K2 serotypes. Furthermore, the capsules in the K1/K2 serotypes were almost hypermucoviscous, but in most cases, the K64 serotype exhibited a regular capsule. Unlike non-virulent strains, hypervirulent strains produce an elevated quantity of capsular substance, thus conferring a hypermucoviscous phenotype (Chen et al., 2004; Alcántar-Curiel and Girón, 2015). However, new evidence has suggested that hypermucoviscosity and hypervirulence are two different phenotypes (Catalán-Nájera et al., 2017). Therefore, it is essential to rapidly identify the genetic determinants of hypermucoviscosity among K. pneumoniae strains.

Capsule production is transcriptionally regulated by multiple proteins. However, very little is known about how these proteins collectively control capsule production. Several studies have reported that rmpA is an important determinant of virulence for the mucoid phenotype of K. pneumoniae (Arakawa et al., 1991). Our studies have proven that knockdown of rmpA reduces mucoviscosity and CPS production, leading to a decrease in the virulence of the strain. This phenomenon is primarily mediated by the regulation of rmpA on three promoters in the cps clusters (including galF, wzi, and manC). Meanwhile, rmpA is a conserved capsular regulator in hvKp strains, ensuring that the synthesis of capsules can be properly regulated. However, hvKp isolates are mainly found to fall into one of several serotypes, including the K1, K2, and K64 serotypes. Furthermore, studies in mice have proven that the capsules of the K1 and K2 strains of K. pneumoniae are more virulent than those of many other strains (Kabha et al., 1995). It has been speculated that different gene clusters play different roles in virulence. Moreover, studies have found that the K1 and K2 strains are significantly more resistant to phagocytosis and intracellular killing by neutrophils than non-K1/K2 strains, suggesting that capsular serotype contributes to increased virulence in K. pneumoniae (Fung et al., 2011). Additionally, Zhang et al. demonstrated that capsule type defines the capacity of K. pneumoniae to evade Kupffer cells in the liver by switching between the expression of different gene clusters (Huang et al., 2022). Based on the above conclusions, diversity of the capsule plays an important role in virulence of hvKp.

Capsule biosynthesis in K. pneumoniae is a complex process, mediated by cps gene clusters. The capsules are formed via a wzy-dependent pathway. WcaJ, an initial glycosyltransferase, is responsible for the transfer of Gal-1-P from UDP-glucose to und-P, thus initiating synthesis of the capsule. Comparative analysis revealed that the wcaJ sequence varies among different serotypes. We constructed several mutants, including K2044^ΔwcaJ, K2044^K1wcaJ, K2044^K2wcaJ, and K2044^K64wcaJ strains, in order to analyze the effects of wcaJ on capsule formation and strain virulence.K2044^ΔwcaJ exhibited decreased mucoviscosity and reduced uronic acid compared to K2044 strains. Meanwhile, the virulence of K2044^ΔwcaJ mutants was significantly reduced, and this was accompanied by a decrease in the release of inflammatory-associated factors. In addition, the disappearance of the “hypercapsule” in K2044^ΔwcaJ strains makes it more likely to be engulfed by phagocytes compared to K2044. However, the presence of a hypercapsule has the opposite effect in other infections. Christoph et al. have proven that hypercapsule production, which confers phagocytosis resistance, enhances dissemination and increases mortality in animal models. In contrast, mutations disrupting capsule biosynthesis impair capsule production, which enhances epithelial cell invasion, in vitro biofilm formation, and persistence in urinary tract infections (Ernst et al., 2020). In our experiment, hypercapsule-null K2044^ΔwcaJ exhibited increased biofilm formation and could invade intestinal epithelial cells easily. The results confirm that wcaJ is of major significance in the synthesis of capsules and the virulence of strains.

We also analyzed the effects of differences in wcaJ sequence on capsule synthesis. The results demonstrated that K2044^K1wcaJ and K2044^K2wcaJ formed a “hypercapsule” similar to that of K2044 isolates, but K2044^K64wcaJ did not. Considering that K2044 is of the K1 serotype, we focused on why K2wcaJ functions in the genetic context of K2044. Protein sequence alignment indicated that there is significantly higher similarity between K1 and K2 than between K1 and K64. In particular, the F244-Y467 protein sequences are completely consistent between the K1 and K2 serotypes, which may constitute the molecular basis for K2wcaJ to function properly. Additionally, K2044^K1wcaJ and K2044^K2wcaJ result in the same effect in terms of virulence as K2044 according to serum resistance and G. mellonella infection models. Meanwhile, our results also revealed that the presence of the capsule effectively induced an inflammatory response (i.e., increased IL-6 and IL-8 levels) following infection with K2044, K2044^K1wcaJ, and K2044^K2wcaJ strains. IL-1β, which is produced by leukocytes, induces the production of IL-6, IL-8, and IL-1β (in a positive feedback loop), creating an unfavorable environment for infectious microorganisms (Boraschi, 2022). However, IFN-γ is not involved in the inflammatory response mediated by K. pneumoniae infection. Notably, the K2044^K1wcaJ and K2044^K2wcaJ strains were found to harbor growth defects compared to K2044.Additionally, taking K2044^ACYC184 as a negative control, the introduction of pACYC184 plasmid did not affect the growth of strains. The results showed that viscosity was increased in K2044^K1wcaJ and K2044^K2wcaJ as compared to K2044, which may be the cause of growth defects. Because of the large number of copies of plasmids, K1wcaJ and K2wcaJ were upregulated in the presence of the plasmid, leading to increased mucoviscosity. However, there was no difference in uronic acid between K2044^K1wcaJ/K2044^K2wcaJ and K2044.

Recent studies have identified two novel transcriptional regulators, RmpC and RmpD. The ΔrmpC strain has reduced capsule gene expression but retains the hypermucoviscous phenotype (Walker et al., 2019). Meanwhile, the ΔrmpD mutant is non-hypermucoviscous, but exhibits no changes in cps expression and produces the same amount of uronic acid (capsule) as the wild-type parental strain (Walker et al., 2020). These transcriptional regulators provide evidence that hypermucoviscosity is not dependent on capsule overproduction (uronic acid). Thus, hypermucoviscosity and CPS production should be treated as two separable phenotypic traits.

To sum up, the interactions of multiple factors are involved in capsule synthesis, including cps cluster loci and certain transcription factors. RmpA, a known capsular regulator gene, is conserved in all kinds of serotypes. RmpA could act on cps cluster promoters simultaneously to promote the production of the hypercapsule. In the meantime, wcaJ acts as an initiation glycosyltransferase gene in CPS synthesis; its knockout results in the loss of the capsule. Unlike rmpA, the consistency of wcaJ sequences is limited to within the same serotype. By constructing the wcaJ recombinations of different serotypes, we have discovered that K2wcaJ may play a role in K2044 (of the K1 serotype), but K64wcaJ does not. Additionally, over-expression of wcaJ led to an increase in viscosity, but the amount of uronic acid did not change. Previous studies have focused on the effects of nucleotide mutations in the capsular gene within the same serotype, such as wcaJ or wzc (Ernst et al., 2020; He et al., 2023). In our study, we analyzed the wcaJ gene in different serotypes, elucidating the mechanism underlying differences in virulence between different serotypes. Our study also has several limitations: firstly, the experiment only involved wcaJ sequences of three serotypes (K1, K2, and K64), and more serotypes needed to be studied; additionally, capsule synthesis involves multiple genes, such as wza, wzc, wzb, wzi, and wzy, and these genes also need to be compared and analyzed in different serotypes.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Author contributions

These authors (including WW, DT and DH) share first authorship. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by National Natural Science Foundation of China under Grants 81871692 and 82172315; the Science and Technology Commission of Shanghai Municipality under Grant 19JC1413002; Shanghai Municipal Key Clinical Specialty under Grant shslczdzk0330; and Jiaxing Municipal Key Laboratory of Infectious Diseases and Bacterial Drug Resistance.

Acknowledgments

We thank Professor JinTown Wang of the Department of Internal Medicine, National Taiwan University Hospital, for authoritative input on NTUH-K2044.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2023.1108818/full#supplementary-material

References

Alcántar-Curiel, M., Girón, J. (2015). Klebsiella pneumoniae and the pyogenic liver abscess: implications and association of the presence of rpmA genes and expression of hypermucoviscosity. Virulence 6 (5), 407–409. doi: 10.1080/21505594.2015.1030101

PubMed Abstract | CrossRef Full Text | Google Scholar

Arakawa, Y., Ohta, M., Wacharotayankun, R., Mori, M., Kido, N., Ito, H., et al. (1991). Biosynthesis of klebsiella K2 capsular polysaccharide in escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain klebsiella pneumoniae chedid (O1:K2). Infect. Immun. 59 (6), 2043–2050. doi: 10.1128/iai.59.6.2043-2050.1991

PubMed Abstract | CrossRef Full Text | Google Scholar

Bachman, M., Breen, P., Deornellas, V., Mu, Q., Zhao, L., Wu, W., et al. (2015). Genome-wide identification of klebsiella pneumoniae fitness genes during lung infection. mBio 6 (3), e00775. doi: 10.1128/mBio.00775-15

PubMed Abstract | CrossRef Full Text | Google Scholar

Boraschi, D. (2022). What is IL-1 for? the functions of interleukin-1 across evolution. Front. Immunol. 13, 872155. doi: 10.3389/fimmu.2022.872155

PubMed Abstract | CrossRef Full Text | Google Scholar

Bushell, S., Mainprize, I., Wear, M., Lou, H., Whitfield, C., Naismith, J. (2013). Wzi is an outer membrane lectin that underpins group 1 capsule assembly in escherichia coli. Structure. (London. Engl. 1993). 21 (5), 844–853. doi: 10.1016/j.str.2013.03.010

CrossRef Full Text | Google Scholar

Catalán-Nájera, J., Garza-Ramos, U., Barrios-Camacho, H. (2017). Hypervirulence and hypermucoviscosity: Two different but complementary klebsiella spp. phenotypes? Virulence 8 (7), 1111–1123. doi: 10.1080/21505594.2017.1317412

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, Y., Chang, H., Lai, Y., Pan, C., Tsai, S., Peng, H. (2004). Sequencing and analysis of the large virulence plasmid pLVPK of klebsiella pneumoniae CG43. Gene 337, 189–198. doi: 10.1016/j.gene.2004.05.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, Z., Cheng, H., Cai, Z., Wei, Q., Li, J., Liang, J., et al. (2021). Identification of microbiome etiology associated with drug resistance in pleural empyema. Front. Cell. Infect. Microbiol. 11, 637018. doi: 10.3389/fcimb.2021.637018

PubMed Abstract | CrossRef Full Text | Google Scholar

Datsenko, K. A., Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U.S.A. 97 (12), 6640–6645. doi: 10.1073/pnas.120163297

PubMed Abstract | CrossRef Full Text | Google Scholar

Ernst, C., Braxton, J., Rodriguez-Osorio, C., Zagieboylo, A., Li, L., Pironti, A., et al. (2020). Adaptive evolution of virulence and persistence in carbapenem-resistant klebsiella pneumoniae. Nat. Med. 26 (5), 705–711. doi: 10.1038/s41591-020-0825-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Follador, R., Heinz, E., Wyres, K., Ellington, M., Kowarik, M., Holt, K., et al. (2016). Klebsiella pneumoniaeThe diversity of surface polysaccharides. Microb. Genomics 2 (8), e000073. doi: 10.1099/mgen.0.000073

CrossRef Full Text | Google Scholar

Fung, C., Chang, F., Lee, S., Hu, B., Kuo, B., Liu, C., et al. (2002). A global emerging disease of klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50 (3), 420–424. doi: 10.1136/gut.50.3.420

PubMed Abstract | CrossRef Full Text | Google Scholar

Fung, C.-P., Chang, F.-Y., Lin, J.-C., Ho, D. M.-T., Chen, C.-T., Chen, J.-H., et al. (2011). Immune response and pathophysiological features of klebsiella pneumoniae liver abscesses in an animal model. Lab. Invest. 91 (7), 1029–1039. doi: 10.1038/labinvest.2011.52

PubMed Abstract | CrossRef Full Text | Google Scholar

He, J., Shi, Q., Chen, Z., Zhang, W., Lan, P., Xu, Q., et al. (2023). Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant klebsiella pneumoniae. Drug Resistance. Updates. Rev. Commentaries. Antimicrob. Anticancer Chemother. 66, 100891. doi: 10.1016/j.drup.2022.100891

CrossRef Full Text | Google Scholar

Huang, X., Li, X., An, H., Wang, J., Ding, M., Wang, L., et al. (2022). Capsule type defines the capability of klebsiella pneumoniae in evading kupffer cell capture in the liver. PloS Pathog. 18 (8), e1010693. doi: 10.1371/journal.ppat.1010693

PubMed Abstract | CrossRef Full Text | Google Scholar

Kabha, K., Nissimov, L., Athamna, A., Keisari, Y., Parolis, H., Parolis, L., et al. (1995). Relationships among capsular structure, phagocytosis, and mouse virulence in klebsiella pneumoniae. Infect. Immun. 63 (3), 847–852. doi: 10.1128/iai.63.3.847-852.1995

PubMed Abstract | CrossRef Full Text | Google Scholar

Lan, P., Jiang, Y., Zhou, J., Yu, Y. (2021). A global perspective on the convergence of hypervirulence and carbapenem resistance in klebsiella pneumoniae. J. Global Antimicrob. Resistance. 25, 26–34. doi: 10.1016/j.jgar.2021.02.020

CrossRef Full Text | Google Scholar

Lee, I., Molton, J., Wyres, K., Gorrie, C., Wong, J., Hoh, C., et al. (2016). Differential host susceptibility and bacterial virulence factors driving klebsiella liver abscess in an ethnically diverse population. Sci. Rep. 6, 29316. doi: 10.1038/srep29316

PubMed Abstract | CrossRef Full Text | Google Scholar

Mike, L., Stark, A., Forsyth, V., Vornhagen, J., Smith, S., Bachman, M., et al. (2021). A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact klebsiella pneumoniae fitness. PloS Pathog. 17 (3), e1009376. doi: 10.1371/journal.ppat.1009376

PubMed Abstract | CrossRef Full Text | Google Scholar

Mizuta, K., Ohta, M., Mori, M., Hasegawa, T., Nakashima, I., Kato, N. (1983). Virulence for mice of klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect. Immun. 40 (1), 56–61. doi: 10.1128/iai.40.1.56-61.1983

PubMed Abstract | CrossRef Full Text | Google Scholar

Paczosa, M., Mecsas, J. (2016). Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. MMBR. 80 (3), 629–661. doi: 10.1128/MMBR.00078-15

CrossRef Full Text | Google Scholar

Russo, T., Marr, C. (2019). Hypervirulent klebsiella pneumoniae. Clin. Microbiol. Rev. 32 (3), e00001–1. doi: 10.1128/CMR.00001-19

CrossRef Full Text | Google Scholar

Russo, T., Olson, R., Fang, C., Stoesser, N., Miller, M., MacDonald, U., et al. (2018). Identification of biomarkers for differentiation of hypervirulent klebsiella pneumoniae from classical k. pneumoniae. J. Clin. Microbiol. 56 (9), e00776–18. doi: 10.1128/JCM.00776-18

PubMed Abstract | CrossRef Full Text | Google Scholar

Shon, A., Bajwa, R., Russo, T. (2013). Hypervirulent (hypermucoviscous) klebsiella pneumoniae: a new and dangerous breed. Virulence 4 (2), 107–118. doi: 10.4161/viru.22718

PubMed Abstract | CrossRef Full Text | Google Scholar

Shu, H. Y., Fung, C. P., Liu, Y. M., Wu, K. M., Chen, Y. T., Li, L. H., et al. (2009). Genetic diversity of capsular polysaccharide biosynthesis in klebsiella pneumoniae clinical isolates. Microbiol. (Reading). 155 (Pt 12), 4170–4183. doi: 10.1099/mic.0.029017-0

CrossRef Full Text | Google Scholar

Struve, C., Roe, C., Stegger, M., Stahlhut, S., Hansen, D., Engelthaler, D., et al. (2015). Mapping the evolution of hypervirulent klebsiella pneumoniae. mBio 6 (4), e00630. doi: 10.1128/mBio.00630-15

PubMed Abstract | CrossRef Full Text | Google Scholar

Tian, D., Liu, X., Chen, W., Zhou, Y., Hu, D., Wang, W., et al. (2022). Klebsiella pneumoniaePrevalence of hypervirulent and carbapenem-resistant under divergent evolutionary patterns. Emerging. Microbes Infect. 11 (1), 1936–1949. doi: 10.1080/22221751.2022.2103454

CrossRef Full Text | Google Scholar

Walker, K., Miller, V. (2020). The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in klebsiella pneumoniae. Curr. Opin. Microbiol. 54, 95–102. doi: 10.1016/j.mib.2020.01.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Walker, K., Miner, T., Palacios, M., Trzilova, D., Frederick, D., Broberg, C., et al. (2019). A klebsiella pneumoniae regulatory mutant has reduced capsule expression but retains hypermucoviscosity. mBio 10 (2), e00089–19. doi: 10.1128/mBio.00089-19

PubMed Abstract | CrossRef Full Text | Google Scholar

Walker, K., Treat, L., Sepúlveda, V., Miller, V. (2020). The small protein RmpD drives hypermucoviscosity in klebsiella pneumoniae. mBio 11 (5), e01750–20. doi: 10.1128/mBio.01750-20

PubMed Abstract | CrossRef Full Text | Google Scholar

Whitfield, C. (2006). Biosynthesis and assembly of capsular polysaccharides in escherichia coli. Annu. Rev. Biochem. 75, 39–68. doi: 10.1146/annurev.biochem.75.103004.142545

PubMed Abstract | CrossRef Full Text | Google Scholar

Whitfield, C., Paiment, A. (2003). Biosynthesis and assembly of group 1 capsular polysaccharides in escherichia coli and related extracellular polysaccharides in other bacteria. Carbohydr. Res. 338 (23), 2491–2502. doi: 10.1016/j.carres.2003.08.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Whitfield, C., Roberts, I. S. (1999). Structure, assembly and regulation of expression of capsules in escherichia coli. Mol. Microbiol. 31 (5), 1307–1319. doi: 10.1046/j.1365-2958.1999.01276.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Xu, Q., Yang, X., Chan, E., Chen, S. (2021). K. pneumoniaeThe hypermucoviscosity of hypervirulent confers the ability to evade neutrophil-mediated phagocytosis. Virulence 12 (1), 2050–2059. doi: 10.1080/21505594.2021.1960101

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, W. L., Ko, W. C., Cheng, K. C., Lee, C. C., Lai, C. C., Chuang, Y. C. (2008). Comparison of prevalence of virulence factors for klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn. Microbiol. Infect. Dis. 62 (1), 1–6. doi: 10.1016/j.diagmicrobio.2008.04.007

PubMed Abstract | CrossRef Full Text | Google Scholar